Hydroxyurea USP For Compounding (API)

Hydroxyurea USP is an active pharmaceutical ingredient used in the production of medicines for the treatment of certain types of cancer, sickle cell disease, and other conditions related to the production of red blood cells. It is a white crystalline powder with the chemical formula CH4N2O2 and is also known as hydroxycarbamide. It works by inhibiting the production of DNA and suppressing the growth of cancer cells and abnormal blood cells. This medication must be prescribed and used under the supervision of a healthcare professional as it can have serious side effects if not used properly.

Hydroxyurea USP for compounding is used to make customized medications for individual patients, typically used to treat chronic myeloid leukemia, sickle cell anemia, and other blood disorders. It is an antineoplastic agent that works by inhibiting the production of DNA in cancer cells, ultimately causing them to die. It is also believed to stimulate the production of fetal hemoglobin in patients with sickle cell disease, which can help improve symptoms and reduce the frequency of painful crises. Compounding pharmacies may use Hydroxyurea USP to create oral suspensions, capsules, topical preparations, or other formulations to meet the specific needs and preferences of patients.

CAS Number: 127-07-1
Properties: Light Sensitive | Hygroscopic